2014-05-13T15:27:59-05:00 2013-06-30 135381590 BDO USA LLP 7101 WISCONSIN AVE SUITE 800 BETHESDA MD 208144827 990 2012-07-01 263690883 THE LIEBER INSTITUTE INC LIEB 4109551013 855 N WOLFE STREET 3RD FLOOR BALTIMORE MD 21205 THOMAS M HYDE MD PHD 4109551013 2014-05-13 1 MICHAEL SORRELLS CPA P00001737 3016544900 2012 2015-11-30 17:44:51Z DANIEL WEINBERGER 855 N WOLFE STREET 3RD FLOOR BALTIMORE MD 21205 15862752 0 X LIBD.ORG X 2008 MD THE MISSION OF THE LIEBER INSTITUTE FOR BRAIN DEVELOPMENT IS THE STUDY OF SCHIZOPHRENIA AND RELATED DISORDERS, IN ORDER TO SPUR THE IDENTIFICATION AND TESTING OF NEW MEDICATIONS TO TREAT SUCH DISORDERS. 9 8 75 0 0 0 953521 150000 549532 527526 1201400 1104915 1479554 1084156 4184007 2866597 450000 450000 0 0 5175377 7715150 0 65000 65043 5374962 7569813 11000339 15799963 -6816332 -12933366 112679813 100309339 5147494 5641028 107532319 94668311 X THE MISSION OF THE LIEBER INSTITUTE FOR BRAIN DEVELOPMENT IS THE STUDY OF SCHIZOPHRENIA AND RELATED DISORDERS, IN ORDER TO SPUR THE IDENTIFICATION AND TESTING OF NEW MEDICATIONS TO TREAT SUCH DISORDERS. 0 0 2645615 200957 STEM CELL BIOLOGY: THE GOAL OF THE STEM CELL BIOLOGY PROJECT IS TO MAP THE MOLECULAR ALTERATIONS THAT ESTABLISH THE GENETIC RISK MECHANISMS FOR SCHIZOPHRENIA AND RELATED PSYCHIATRIC DISORDERS, AND THEN TO USE THIS INSIGHT TO DEVELOP DRUG ASSAYS AND POTENTIALLY DIAGNOSTIC TOOLS. THE PROJECT WILL DEVELOP THE CAPABILITY TO EXPLORE THE CELL PATHOLOGY ASSOCIATED WITH GENETIC RISK FOR PSYCHIATRIC ILLNESS AT THE LEVEL OF HUMAN EMBRYONIC STEM CELLS. 2139700 100000 207778 CLINICAL GENETICS AND BIOINFORMATICS: THE CLINICAL GENETICS AND BIOINFORMATICS CORE PROJECT WILL BE FOCUSED ON MOVING GENETIC ASSOCIATION TO THE CLINICAL LEVEL AND TO GUIDING THE GENETIC WORK OF THE OTHER PROJECTS THROUGH STATISTICAL ANALYSIS. THIS PROJECT WILL FOCUS ON THE GENETIC RISK ARCHITECTURE FOR SCHIZOPHRENIA, AND ITS INTERFACE WITH ENVIRONMENTAL FACTORS THAT INCREASE THE LIABILITY FOR THE DEVELOPMENT OF THIS DISORDER. 1972957 DEVELOPMENTAL NEUROBIOLOGY: THE GOAL OF THE DEVELOPMENTAL NEUROBIOLOGY AND FUNCTIONAL GENOMICS PROJECT IS TO INTERROGATE THE MOLECULAR PATHOLOGY OF SCHIZOPHRENIA, WITH A FOCUS ON RISK ASSOCIATED GENES. WITH THIS INFORMATION, THIS PROJECT WILL CREATE MODEL SYSTEMS TO STUDY THE PATHOGENESIS OF SCHIZOPHRENIA AND RELATED NEURODEVELOPMENTAL PSYCHIATRIC DISORDERS. 1426479 DRUG DEVELOPMENT: THE GOAL OF THIS PROJECT IS TO CAST A BROAD NET TO IDENTIFY MOLECULAR SIGNALING SYSTEMS WHEREIN INTERVENTION DRUGS MAY ATTACK MAJOR MENTAL DISORDERS, INCLUDING SCHIZOPHRENIA. THE GOAL OF THE DRUG DISCOVERY UNIT IS TO ADD VALUE TO BASIC RESEARCH FINDINGS THAT APPEAR RELEVANT TO THE CREATION OF NEW DRUG THERAPIES- AND ENABLING THE INSTITUTE TO FIND A TREATMENT OR CURE FOR SCHIZOPHRENIA IN ACCORDANCE WITH ITS EXEMPT PURPOSE. 1812205 118791 COGNITIVE NEUROSCIENCE AND NEUROIMAGING GENETICS: THE GOAL OF THIS PROJECT, WITHIN THE FIRST FEW YEARS, IS TO DEVELOP AN EXTENSIVE DATABASE OF DEVELOPMENTAL AND COGNITIVE VARIABLES, INCLUDING BRAIN PHYSIOLOGY, IN 500 NORMAL SUBJECTS FROM AGES 5 THROUGH 50 BASED ON DETAILED DEVELOPMENTAL HISTORIES, COGNITIVE AND PERSONALITY TESTING,FUNCTIONAL MAGNETIC RESONANCE IMAGING, ELECTROENCEPHALOGRAPHY AND MAGNETO ENCEPHALOGRAPHY STRATEGIES. PARADIGMS DEVELOPED IN THIS PROJECT WILL BE USED TO ASSESS THE EFFICACY OF NOVEL TREATMENT STRATEGIES DURING LATER STAGES OF THE INSTITUTE'S WORK AND TO DEVELOP MODELS OF RISK ASSESSMENT. 229455 CLINICAL PHARMACOLOGY. 350000 350000 EXTRAMURAL GRANTS. 3818139 350000 118791 10576411 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 47 0 1 75 1 0 0 0 0 0 0 0 0 0 0 X 9 8 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X YOLANDA DUDLEY 4109551013 855 N WOLFE STREET SUITE 300 BALTIMORE MD 21205 HERBERT PARDES MD 1.00 X X 0 0 0 STEVE LIEBER 1.00 X 0 0 0 CONSTANCE LIEBER 1.00 X X 0 0 0 SAMUEL LIEBER 1.00 X X 0 0 0 MARY RUBIN 1.00 X 0 0 0 TAMAR MALTZ 1.00 X 0 0 0 MILTON MALTZ 1.00 X 0 0 0 DANIEL R WEINBERGER 40.00 X X 503185 0 11131 THOMAS M HYDE 40.00 X 284679 0 21474 TARA ESKANDARI 40.00 X 116780 0 10033 RON MCKAY 40.00 X 352682 0 10979 JIM BARROW 40.00 X 193414 0 24654 RICHARD STRAUB 40.00 X 153133 0 24212 YUAN GAO 40.00 X 165319 0 24435 JOHN MEYERS 40.00 X 147635 0 20013 VENKATA MATTAY 40.00 X 244239 0 21708 XI CHENG 40.00 X 134134 0 15974 2295200 0 184613 16 0 1 0 KING AND SPALDING LLP PO BOX 116133 ATLANTA GA 303686133 LEGAL 336800 ARNOLD & PORTER PO BOX 37116 BALTIMORE MD 21297 LEGAL 191453 TRINET 1100 SAN LEANDRO BLVD 400 SAN LEANDRO CA 94577 PAYROLL AND BENEFITS 123123 SCD INFORMATION TECHNOLOGY 6630 ELI WITNEY DRIVE SUITE E COLUMBIA MD 21046 IT 114102 4 150000 150000 CONTRACT REVENUE 900099 527526 527526 527526 1056254 1056254 13044816 12996155 48661 48661 48661 AMORT.CONTRIB.DISC. 900099 998779 998779 MISCELLANEOUS 900099 85377 85377 1084156 2866597 527526 0 2189071 350000 350000 100000 100000 1584142 1103938 480204 4964297 4515264 449033 141056 122492 18564 569927 510531 59396 455728 398974 56754 452811 82177 370634 44539 44539 65000 65000 327923 94892 233031 432647 294871 137776 241546 39023 202523 2015841 79696 1936145 180789 141493 39253 43 66605 32613 33992 71715 25715 46000 1584604 672347 912257 37523 199 37324 GENERAL LAB SUPPLIES 1694666 1691723 2943 OTHER LAB EXPENSE 246654 246654 171950 73809 98141 15799963 10576411 5158509 65043 2533455 533046 6156659 12639901 56576792 36915387 344821 59028 205203 95057 13153250 2909740 10104511 10243510 36543162 39608451 215210 214959 112679813 100309339 725484 1114431 460468 563407 2300000 2300000 1661542 1663190 5147494 5641028 X 45261513 52307148 62270806 42361163 107532319 94668311 112679813 100309339 -12933366 69358 0 X 0 1 X 0 0 X JOHNS HOPKINS UNIVERSITY HOSPITAL BALTIMORE MD RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 7055516 1133644 5921872 5444861 1574887 3869974 652873 201209 451664 10243510 DEFERRED RENT 1345926 CAPITAL LEASE 317264 1663190 X 2935955 69358 69358 2866597 0 2866597 15799963 0 15799963 0 15799963 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: THE INSTITUTE FOLLOWS THE PROVISIONS OF ASC 740-10 RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. INCOME TAX BENEFITS ARE RECOGNIZED FOR INCOME TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, ONLY WHEN IT IS DETERMINED THAT THE INCOME TAX POSITION WILL MORE-LIKELY-THAN-NOT BE SUSTAINED UPON EXAMINATION BY TAXING AUTHORITIES. THE INSTITUTE ANALYZED TAX POSITIONS TAKEN FOR FILING WITH THE INTERNAL REVENUE SERVICE AND ALL STATE JURISDICTIONS WHERE IT OPERATES. THE INSTITUTE BELIEVES THAT INCOME TAX FILING POSITIONS WILL BE SUSTAINED UPON EXAMINATION AND DOES NOT ANTICIPATE ANY ADJUSTMENTS THAT WOULD RESULT IN A MATERIAL ADVERSE EFFECT ON THE INSTITUTE'S FINANCIAL CONDITION, RESULTS OF OPERATIONS OR CASH FLOWS. ACCORDINGLY, THE INSTITUTE HAS NOT RECORDED ANY RESERVES, OR RELATED ACCRUALS FOR INTEREST AND PENALTIES FOR UNCERTAIN INCOME TAX POSITIONS AT JUNE 30, 2013 AND 2012. THE INSTITUTE IS SUBJECT TO ROUTINE AUDITS BY TAXING JURISDICTIONS FROM FISCAL YEAR END 2010 FORWARD; HOWEVER, THERE ARE CURRENTLY NO AUDITS FOR ANY OPEN TAX PERIODS. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - 0 0 GRANTS RESEARCH 100000 0 0 0 0 0 0 100000 0 100000 EUROPE (INCLUDING ICELAND & GREENLAND) - RESEARCH 100000 WIRE TRANSFERS 1 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: THIS AGREEMENT PROVIDES FOR MONITORING OF GRANT FUNDS. X X 1 COMMUNITY COUNSELING SERVICE PO BOX 824885 PHILADELPHIA PA 19182 PLANNING SESSIONS AND A REVENUE GENERATION STRATEGY REPORT. 0 0 65000 -65000 65000 -65000 1 COLUMBIA UNIVERSITY PO BOX 29789 NEW YORK NY 100879789 135598093 501(C)(3) 350000 COLLABORATION AGREEMENT 1 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: THE ONLY GRANT MADE WAS TO COLUMBIA UNIVERSITY UNDER A COLLABORATION AGREEMENT. THIS AGREEMENT PROVIDES FOR MONITORING OF GRANT FUNDS. X 1 1 X X 0 0 0 0 0 0 0 0 0 DANIEL R WEINBERGER 503185 0 0 0 0 0 7500 0 3631 0 514316 0 0 0 THOMAS M HYDE 284679 0 0 0 0 0 7500 0 13974 0 306153 0 0 0 RON MCKAY 347682 0 5000 0 0 0 7500 0 3479 0 363661 0 0 0 JIM BARROW 193414 0 0 0 0 0 7500 0 17154 0 218068 0 0 0 RICHARD STRAUB 153133 0 0 0 0 0 5592 0 18620 0 177345 0 0 0 YUAN GAO 165319 0 0 0 0 0 7500 0 16935 0 189754 0 0 0 JOHN MEYERS 145135 0 2500 0 0 0 3004 0 17009 0 167648 0 0 0 VENKATA MATTAY 239239 0 5000 0 0 0 1250 0 20458 0 265947 0 0 0 XI CHENG 129134 0 5000 0 0 0 675 0 15299 0 150108 0 0 0 PART I, LINE 1A THE ORGANIZATIONAL TRAVEL POLICY ALLOWS FOR FIRST CLASS TRAVEL FOR DESTINATIONS ABROAD. STEVE LIEBER DIRECTOR 23518012 FOUNDING PARTNER OF ALPINE WOODS CAPITAL INVESTORS LLC WHERE THE ORGANIZATION HAS SIGNIFICANT INVESTMENTS 0 SAMUEL LIEBER DIRECTOR AND TREASURER 23518012 CHIEF EXECUTIVE OFFICER OF ALPINE WOODS CAPITAL INVESTORS LLC WHERE THE ORGANIZATION HAS SIGNIFICANT INVESTMENTS 0 FORM 990, PART VI, SECTION A, LINE 2 STEVE LIEBER, CONSTANCE LIEBER, SAMUEL LIEBER AND MARY RUBIN HAVE A FAMILY RELATIONSHIP. TAMAR AND MILTON MALTZ HAVE A FAMILY RELATIONSHIP. STEVE LIEBER AND SAMUEL LIEBER HAVE A BUSINESS RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTANT AND REVIEWED IN DRAFT FORM BY MANAGEMENT AND THE ORGANIZATION'S ATTORNEY. IT IS CIRCULATED TO THE BOARD OF DIRECTORS VIA EMAIL PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THERE ARE TWO CONFLICT OF INTEREST POLICIES. ONE GOVERNS DIRECTORS, OFFICERS AND KEY EMPLOYEES. PURSUANT TO THIS POLICY, THE COVERED PERSONS MUST SUBMIT A CONFLICT OF INTEREST DISCLOSURE FORM WHEN THEY JOIN OR ARE APPOINTED AND ANNUALLY THEREAFTER. THE SECOND POLICY PRIMARILY GOVERNS RESEARCHERS. ALL COVERED EMPLOYEES UNDER THIS POLICY ARE REQUIRED TO SIGN THE CONFLICT OF INTEREST POLICY UPON COMMENCEMENT OF EMPLOYMENT. COVERED PERSONS UNDER EACH POLICY ARE REQUIRED TO DISCLOSE NEW CONFLICTS OF INTEREST TO MANAGMENT AS SOON AS THEY ARISE. THE ORGANIZATION IS IN THE PROCESS OF ESTABLISHING A PROCESS FOR REVIEWING COMPENSATON. AN INDEPENDENT FIRM WILL BE HIRED TO PROVIDE AN INITIAL REVIEW OF COMPENSATION AND GUIDANCE WITH RESPECT OT POLICIES AND PROCEDURES TO BE FOLLOWED. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.